Tuesday, 14 July 2020 »  Login
in
»
I am at

Hetero Launching Remdesivir In India For Covid

Hyderabad-based Hetero has received the manufacturing and marketing approval for the investigational antiviral medicine from the DCGI for the treatment of Covid-19.
Hyderabad | 21st June 2020
Hyderabad-based Hetero, one of India's leading generic pharmaceutical companies, announced today that it had received the manufacturing and marketing approval for the investigational antiviral medicine Remdesivir from the Drug Controller General of India (DCGI) for the treatment of Covid-19.

Hetero's generic version of Remdesivir will be marketed under the brand name Covifor in India.

Dr B Partha Saradhi Reddy, the Chairman of the Hetero group of companies, said, "In the light of increasing Covid-19 cases in India, the approval of Covifor can prove to be a game-changer given its positive clinical outcomes. Backed by strong backward integration capabilities, we can ensure that the product is immediately made available to patients across the country. We are prepared for ensuring enough stocks required to cater to the present needs. We will continue to work closely with the government and medical community to make a difference in the fight against Covid-19. This product is made indigenously in line with the 'Make in India' campaign as envisioned by our Prime Minister."

The drug Remdesivir has been granted approval by the DCGI for the treatment of suspected or laboratory-confirmed cases of Covid-19 in adults and children, hospitalized with severe symptoms of the disease. Covifor will be available in a 100 mg vial (injectable) which has to be administered intravenously in a hospital setting under the supervision of a healthcare practitioner.

The product was launched under a licensing agreement with Gilead Sciences Inc to expand access to Covid-19 treatment in low and middle-income countries.
filed in:  Coronavirus, Drugs, Hetero Drugs
COMMENTS
Be the first to comment on Hetero Launching Remdesivir In India For Covid! Just use the simple form below.
LEAVE A COMMENT
fullhyd.com has 700,000+ monthly visits. Tell Hyderabad what you feel about Hetero Launching Remdesivir In India For Covid!
[no link to your name will appear, overriding global settings]
To preserve integrity, fullhyd.com allows ratings/comments only with a valid email. Your comments will be accepted once you give your email, and will be deleted if the email is not authenticated within 24 hours.
My name:

Dissatisfied with the results? Report a problem or error, or add a listing.
ADVERTISEMENT
SHOUTBOX!
{{todo.name}}
{{todo.date}}
[
]
{{ todo.summary }}... expand »
{{ todo.text }} « collapse
First  |  Prev  |   1   2  3  {{current_page-1}}  {{current_page}}  {{current_page+1}}  {{last_page-2}}  {{last_page-1}}  {{last_page}}   |  Next  |  Last
{{todos[0].name}}

{{todos[0].text}}

ADVERTISEMENT
This page was tagged for
remdesivir drug rep in hyderabad india
hyderabad June 2020 News
Coronavirus news
Drugs updates
Follow fullhyd.com on
© Copyright 1999-2009 LRR Technologies (Hyderabad), Pvt Ltd. All rights reserved. fullhyd, fullhyderabad, Welcome To The Neighbourhood are trademarks of LRR Technologies (Hyderabad) Pvt Ltd. The textual, graphic, audio and audiovisual material in this site is protected by copyright law. You may not copy, distribute, or use this material except as necessary for your personal, non-commercial use. Any trademarks are the properties of their respective owners. More on Hyderabad, India. Jobs in Hyderabad.